These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 3008639)

  • 1. Cytoskeletal protein abnormalities in neurodegenerative diseases.
    Goldman JE; Yen SH
    Ann Neurol; 1986 Mar; 19(3):209-23. PubMed ID: 3008639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermediate filaments and ubiquitin: a new thread in the understanding of chronic neurodegenerative diseases.
    Mayer RJ; Lowe J; Lennox G; Doherty F; Landon M
    Prog Clin Biol Res; 1989; 317():809-18. PubMed ID: 2557642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Filamentous nerve cell inclusions in neurodegenerative diseases: tauopathies and alpha-synucleinopathies.
    Goedert M
    Philos Trans R Soc Lond B Biol Sci; 1999 Jun; 354(1386):1101-18. PubMed ID: 10434313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axonal transport in neurological disease.
    Griffin JW; Watson DF
    Ann Neurol; 1988 Jan; 23(1):3-13. PubMed ID: 3278671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin and the lysosome system: molecular immunopathology reveals the connection.
    Mayer RJ; Lowe J; Landon M; McDermott H; Tuckwell J; Doherty F; László L
    Biomed Biochim Acta; 1991; 50(4-6):333-41. PubMed ID: 1666279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model for slow axonal transport and its application to neurofilamentous neuropathies.
    Blum JJ; Reed MC
    Cell Motil Cytoskeleton; 1989; 12(1):53-65. PubMed ID: 2468419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytoskeletal changes in Alzheimer's disease and other neurodegenerative disorders].
    Astarloa R; Alvarez-Cermeño JC
    Neurologia; 1990 Feb; 5(2):52-61. PubMed ID: 2141790
    [No Abstract]   [Full Text] [Related]  

  • 8. [Neurospecific cytoskeletal proteins].
    Berezin VA; Shevchenko GM
    Ukr Biokhim Zh (1978); 1987; 59(1):105-15. PubMed ID: 3544407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin is a common factor in intermediate filament inclusion bodies of diverse type in man, including those of Parkinson's disease, Pick's disease, and Alzheimer's disease, as well as Rosenthal fibres in cerebellar astrocytomas, cytoplasmic bodies in muscle, and mallory bodies in alcoholic liver disease.
    Lowe J; Blanchard A; Morrell K; Lennox G; Reynolds L; Billett M; Landon M; Mayer RJ
    J Pathol; 1988 May; 155(1):9-15. PubMed ID: 2837558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathology of the cytoskeleton].
    Dustin P; Brion JP
    Ann Pathol; 1988; 8(1):3-19. PubMed ID: 3293578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermediate filament-ubiquitin diseases: implications for cell sanitization.
    Mayer RJ; Lowe J; Lennox G; Landon M; MacLennan K; Doherty FJ
    Biochem Soc Symp; 1989; 55():193-201. PubMed ID: 2559734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Intermediate filaments: biochemical markers of nerve cells and their neuropathological implications].
    Astarloa R; Gobernado JM
    Neurologia; 1988; 3(4):148-57. PubMed ID: 3078764
    [No Abstract]   [Full Text] [Related]  

  • 13. The complexity of intermediate filaments in the nervous system.
    Leung CL; Flores RL; Liem RK
    Subcell Biochem; 1998; 31():497-526. PubMed ID: 9932504
    [No Abstract]   [Full Text] [Related]  

  • 14. 6-hydroxydopamine-induced lesions of dopaminergic neurons alter the function of postsynaptic cholinergic neurons without changing cytoskeletal proteins.
    Muma NA; Lee JM; Gorman L; Heidenreich BA; Mitrovic I; Napier TC
    Exp Neurol; 2001 Mar; 168(1):135-43. PubMed ID: 11170728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A proteomic approach to assess intraneuronal inclusions associated with neurodegenerative disorders.
    Kawaja MD
    Curr Opin Mol Ther; 2005 Dec; 7(6):565-8. PubMed ID: 16370379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intermediate filaments in biology and disease.
    Revis Biol Celular; 1989; 22():1-80. PubMed ID: 2699767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transgenic zebrafish model of neurodegeneration.
    Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
    J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Superoxide dismutase may lead to cytoskeletal abnormalities and amyotrophic lateral sclerosis.
    Brenner S
    Ann Neurol; 2008 Sep; 64(3):357-8; author reply 358. PubMed ID: 18409199
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurofilament subunit--related proteins in neuronal intranuclear inclusions.
    Palo J; Haltia M; Carpenter S; Karpati G; Mushynski W
    Ann Neurol; 1984 Apr; 15(4):322-8. PubMed ID: 6331276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for neurofilament inclusion disease using alpha-internexin immunohistochemistry.
    Uchikado H; Shaw G; Wang DS; Dickson DW
    Neurology; 2005 May; 64(9):1658-9. PubMed ID: 15883343
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.